India
Haematology · 4 min read

Rh deficiency syndrome

Learn about Rh deficiency syndrome, its reported features, relevant specialists, and questions to discuss at a medical consultation.

Also known as: Rh-null syndrome

Compiled from public sources
Text selected and arranged from Orphanet. It describes the condition as those sources do; it has not been rewritten for India.
01 Oct 2026
Not medically reviewed
No registered doctor has reviewed this page. Use it to decide who to see and what to ask — not to diagnose or treat.
—
This is not medical advice. If symptoms are severe, sudden or getting worse, call 112 (or 108 for an ambulance) or go to the nearest emergency department.

The sources compiled here do not cover: diagnosis, treatment, prevention, prognosis, prevalence. Ask the treating doctor about these.

What it is

From: Orphanet

A rare constitutional hemolytic anemia due to a red cell membrane anomaly characterized by lack or severe reduction of Rh blood group antigens, resulting in increased osmotic fragility of red blood cells and chronic hemolytic anemia of varying severity with stomatocytosis and spherocytosis. Two types of the syndrome arising from independent genetic mechanisms have been distinguished: the regulator type is caused by defects of the Rh associated glycoprotein (encoded by the RHAG gene), while the amorph type is due to mutations at the RH locus itself.

Reported clinical features and what the terms mean

The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.

The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.

Hemolytic anemia · Very frequent (99-80%)
A type of anemia caused by premature destruction of red blood cells (hemolysis).
Positive direct antiglobulin test · Very frequent (99-80%)
A positive result of the direct antiglobulin test (DAT), a method of demonstrating the presence of antibody or complement bound to red blood cell (RBC) membranes by the use of anti-human globulin to form a visible agglutination reaction.
Reduced haptoglobin level · Very frequent (99-80%)
The concentration of haptoglobin in the blood circulation is below the lower limit of normal.
Reticulocytosis · Very frequent (99-80%)
An elevation in the number of reticulocytes (immature erythrocytes) in the peripheral blood circulation.
Increased red cell osmotic fragility · Very frequent (99-80%)
Hyperbilirubinemia · Frequent (79-30%)
An increased amount of bilirubin in the blood.
Hypochromia · Frequent (79-30%)
A qualitative impression that red blood cells have less color than normal when examined under a microscope, usually related to a reduced amount of hemoglobin in the red blood cells.
Increased circulating lactate dehydrogenase concentration · Frequent (79-30%)
An elevated level of the enzyme lactate dehydrogenase in the blood circulation.
Spherocytosis · Frequent (79-30%)
The presence of erythrocytes that are sphere-shaped.
Stomatocytosis · Frequent (79-30%)
The presence of erythrocytes with a mouth-shaped (stoma) area of central pallor on peripheral blood smear.
Anisocytosis · Occasional (29-5%)
Abnormally increased variability in the size of erythrocytes.
Hepatosplenomegaly · Occasional (29-5%)
Simultaneous enlargement of the liver and spleen.
Hypoxemia · Occasional (29-5%)
An abnormally low level of blood oxygen.
Intrauterine growth retardation · Occasional (29-5%)
An abnormal restriction of fetal growth with fetal weight below the tenth percentile for gestational age.

Other findings in the same source

From: Orphanet

Additional reported features include Jaundice (Occasional (29-5%)); Oligohydramnios (Occasional (29-5%)); Spontaneous abortion (Occasional (29-5%)); Tachycardia (Occasional (29-5%)); Tachypnea (Occasional (29-5%)); Macrocytic anemia (Very rare (<4-1%)). This is a selected summary, not a complete description of the condition.

When it may begin

From: Orphanet

No data available

Inheritance in the source

From: Orphanet

Autosomal recessive

Understanding the inheritance label

From: MedlinePlus Genetics

An autosomal recessive pattern usually involves disease-causing changes in both copies of a gene. Parents may each carry one altered copy without having the condition themselves. A genetic counsellor can explain carrier testing and reproductive implications using the actual laboratory findings, rather than the condition name alone.

Which doctor should you see?

The suggested department for discussing Rh deficiency syndrome is Haematology, with a haematologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.

Additional services that may be relevant, depending on the findings, include: Clinical Genetics.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

  • Which blood-cell, marrow, bleeding or clotting finding matters most?
  • Does the diagnosis need confirmation or a more precise subtype?
  • Which symptoms or laboratory changes should trigger earlier review?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Rh deficiency syndrome. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.

Find a doctor for Rh deficiency syndrome

This condition is usually assessed by a haematologist. Every profile shows the doctor’s registration and what has been checked.

All haematology conditions →

Sources

Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.

General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-2054.